Uniplan Investment Counsel’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,062
Closed -$1.54M 138
2021
Q3
$1.54M Sell
2,062
-9
-0.4% -$7.53K 0.09% 131
2021
Q2
$2.16M Buy
2,071
+11
+0.5% +$13.2K 0.13% 129
2021
Q1
$3.07M Buy
2,060
+6
+0.3% +$8.72K 0.2% 89
2020
Q4
$2.18M Sell
2,054
-90
-4% -$81.8K 0.15% 106
2020
Q3
$1.54M Buy
+2,144
New +$2.05M 0.11% 110

Other funds holding YCBD

Uniplan Investment Counsel's YCBD Position: Q4 2021 in Review

Uniplan Investment Counsel sold out of cbdMD (YCBD) in Q4 2021, closing a stake of 2,062 shares — an estimated $1.54M sold.

Uniplan Investment Counsel first reported a position in YCBD in Q3 2020 and held it in 5 quarters. The position peaked at $3.07M in Q1 2021. 51 funds tracked by Wall St. Rank hold YCBD as of Q4 2021.

  • Uniplan Investment Counsel reported no remaining cbdMD position as of Q4 2021 after selling out during the quarter.
  • Uniplan Investment Counsel sold 2,062 cbdMD shares in Q4 2021, an estimated $1.54M.
  • Uniplan Investment Counsel first reported a position in cbdMD in Q3 2020 and held it in 5 quarters.
  • Uniplan Investment Counsel's cbdMD position peaked at $3.07M in Q1 2021.
  • 51 funds tracked by Wall St. Rank held cbdMD as of Q4 2021.

Based on Uniplan Investment Counsel's 13F filing for Q4 2021, filed 14 Feb 2022.